Individuals on Tirzepatide (n = 50) reported a median dose of 7.5 mg [range 0.515 mg], and on Semaglutide variants: Ozempic or Wegovy (n = 54) reported a median dose of 1 [range 0.252.4] and Rybelsus (n = 2) reported doses of 7 mg and 14 mg
These changes are not always tied to a single lab value
Meet with a provider in-office in Hollywood, Florida or through secure telehealth
This treatment has been proven to help reduce body fat, particularly visceral fat, which is associated with various health risks such as heart disease, diabetes, and hypertension
You may be experiencing Restless Leg Syndrome (RLS) , a common but often misunderstood condition that affects sleep, comfort, and quality of life
Most studies have focused on the UA transporter genes ABCG2 and SLC2A9